Back |
home / stock / xair / xair message board
Subject | By | Source | When |
---|---|---|---|
https://gravityanalytica.com/protected/analyzer/XAIR-b1879d1ce0-2020-07-06. | swingingRichard | investorshub | 07/06/2020 12:53:22 AM |
Just realized that the short interest | boston127 | investorshub | 04/04/2020 3:09:13 PM |
AH is looking very good here. | boston127 | investorshub | 03/24/2020 5:43:42 AM |
Hey good looking. | boston127 | investorshub | 03/24/2020 5:18:21 AM |
Good volume. Looking to see continual | boston127 | investorshub | 03/23/2020 8:38:48 PM |
$XAIR - Good morning boston!....Looks very interesting.... | janetcanada | investorshub | 03/23/2020 12:57:43 PM |
iNO products may get the green light from FDA... | Marvy | investorshub | 03/23/2020 11:25:55 AM |
Looks like the possibility of FDA | boston127 | investorshub | 03/23/2020 10:25:21 AM |
Trying to find out why the major | boston127 | investorshub | 03/23/2020 10:04:32 AM |
Nice move today and after hours. | boston127 | investorshub | 03/21/2020 3:03:38 AM |
whytestocks: $AITB News Article - AIT Therapeutics Announces Uplisting to the Nasdaq Capital Market | whytestocks | investorshangout | 05/03/2019 12:45:40 PM |
whytestocks: $AITB News Article - AIT Therapeutics to Demonstrate NO Generator and Delivery System a | whytestocks | investorshangout | 04/23/2019 1:20:42 PM |
PoemStone: $AITB higher highs / Pr $4.95 OTC | PoemStone | investorshangout | 01/24/2019 2:55:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Beyond Air Inc. Company Name:
XAIR Stock Symbol:
NYSE Market:
HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentrat...
HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced being selected to present on the clinical development program of its Ult...
Beyond Air(R) (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (“NO”) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumor...